A detailed history of Smith Anglin Financial, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Smith Anglin Financial, LLC holds 499 shares of LLY stock, worth $397,039. This represents 0.04% of its overall portfolio holdings.

Number of Shares
499
Previous 457 9.19%
Holding current value
$397,039
Previous $413,000 7.02%
% of portfolio
0.04%
Previous 0.04%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$772.14 - $960.02 $32,429 - $40,320
42 Added 9.19%
499 $442,000
Q2 2024

Jul 10, 2024

SELL
$724.87 - $909.04 $24,645 - $30,907
-34 Reduced 6.92%
457 $413,000
Q1 2024

Apr 24, 2024

SELL
$592.2 - $792.28 $58,627 - $78,435
-99 Reduced 16.78%
491 $381,000
Q3 2023

Oct 11, 2023

SELL
$434.7 - $599.3 $66,074 - $91,093
-152 Reduced 20.49%
590 $316,000
Q2 2023

Jul 10, 2023

SELL
$350.74 - $468.98 $9,820 - $13,131
-28 Reduced 3.64%
742 $347,000
Q1 2023

Apr 11, 2023

BUY
$310.63 - $364.82 $33,548 - $39,400
108 Added 16.31%
770 $264,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $10,932 - $12,738
34 Added 5.41%
662 $242,000
Q3 2022

Oct 24, 2022

BUY
$296.48 - $337.87 $186,189 - $212,182
628 New
628 $203,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Smith Anglin Financial, LLC Portfolio

Follow Smith Anglin Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Anglin Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Anglin Financial, LLC with notifications on news.